The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Boyzee - I don't think it's an easy process to remove a Nomad. They have to apply to AIM with a valid, backed up reason in order to have them removed. Having said that, I'm not sure it's the Nomad that needs to be removed. FinnCap are the one's that cocked up the placing. If TW is correct with his assessment of events, Finncap would have us sitting at 5p now.
I agree, volume is immensely important and the placing stifled the volume build up that should have manifested immediately after the settlement announcement. A point to note, a placing is officially a closed period, so this in itself restricts anyone remotely connected to the company or associated companies from trading. With the placing out of the way we should see a material change.
Florida ... wish I had your optimism and confidence. Pray tell me why our great nomad hasnt been sacked? Does it hold too much delicate info? Just wondered if you could put a positive spin on this point. The mm.s are not the ones to blame.The imbalance between the share supply and demand is. The need to deliver normal mkt size trading in a shakey, low volume share allows the mm.s to justify their tactics. I loved it in the early days here ...I was in vialogy first(fool!) And then was charmed by DrLittle. Reynolds doesnt charm me - he.s too entwined with the gravy train establishment whi tend to look after themselves first. Anyway, just to say I very much value your posts and enjoy reading them and your retorts. Tk care ...
I must say I expected, the recent character assasinations of BOD members to materialise next week, now seems a little early. However, although, I'm sure his wife wouldn't agree, Adam Reynaulds assumed playboy style does set him up as an easy target. I originally bought into this company because the product was good, had a beleivable CEO and a chairman who had an incredible reputation for turning badly run companies into astonishing successes, Optobiotics, listed at the same time as Premaitha is a perfect example. There are and will be many in the lead up to the 25th, as I have said before, who will attack the BOD with personal abuse. This is IMV standard prcatice for placings, so don't be surprised. The MM's know there could be a rush of buying and they want to slow it down by attacking the only thing left to attack, just don't believe what they say.
Usually I would come out guns blazing when someone makes themselves out to be an absolute idiot, but on this occasion I hold back on the basis that LTH Bakky seems to have inadvertently drawn himself into the firing line and I would prefer not to include him in my condescending vitriol that follows.
Dibs - Lets start from the beginning - you said -
"No one seems to have spotted that they actually released a trading update with the full year results. And now, two weeks later they release another trading update for the same period. The difference between the two - £100k. Not worth it was it. Just looks desperate. The other thing to note is that they are comparing to H1 the previous year. Sorry Lyn you won’t get away with that one, this is NOT a seasonal business. If you compare to the previous half year period the growth is far smaller. So, what can we deduce from this once we use relevant statistics. We can deduce that costs/expenses are growing faster than revenues and that’s why they said they would focus on this, because they can see it is a major issue. "
My reply to this -
"The recent update was up until the 31st March 2018. Figures mentioned up to 30th September were projections only (40% increase). Todays RNS was confirmation that those projections were accurate and correct (45% increase)."
You were totally wrong on everything stated.
You said -
"The other thing that looks desperate is to mention the litigation yet again. The ‘dividend’ from that has disappeared Lyn."
My reply to this -
"Litigation in the yearly update to the 31st March mentioned only that it was lifted. This RNS clarified and confirmed the legal proceedings were completed."
Clearly no repetition by the CEO or any intention to capitalise on repeated references to litigation. Again you have no foundation of truth.
You said -
"They need possibly several fundraising’s in the next year or more to get through this period."
My reply to this -
"Further fundraisings were only mentioned in the last paragraph of the year ending 31st March update - going concern. This was only in the context of a possibility within the next 12 months. I repeat, a going concern paragraph is a requirement applied to all companies under stock market rules for the protection of the public."
You clearly had no evidence that multiple placings would definitely occur, and you inferred that these placings were somehow imminent. I on the other hand, made no claim whatsoever that there would be no further placings. I did in fact make clear an additional placing could take place withn 12 months, as stated in the going concern. As I have already said, a going concern is subject to a multitude of variables that could determine whether or not a placing would take place. It is not a given, and because it is stated within a going concern should not be taken as a given. More, I'm sure, will be mentioned at the AGM to clarify this position.
Yes ... but it.s a long time ago and times have changed. I agree that gaps tend to be filled ... have played on that many times. Lets hope it can be - that price would be rather nice. Come on India, Kenya, Sth Africa ... get reproducing ...
I would like to touch upon an area of discussion although maybe controversial, but relevant, and that is Technical Analysis.
I do find the statement about the floor for TMO warrants (24p)according to flipper's analysis interesting as it coincides with an interesting aspect of technical analysis. Let me explain.
When a share price is showing higher highs and higher lows over time(especially after a significant fall), gaps in a chart tend to be filled on a high percentage. This has happened with lloyds(5/5/2011@52.9p), HSBC(04/01/2016@572p) and many more shares over time. If you look at a daily chart of NIPT on the 02/07/2015, you will notice a gap from the price 23.48 pence that has not been filled yet!! So looking at past performance of share's filling gaps and flippers comprehensive fundamental analysis, it doesn't take a genius to work out the potential gain from here.
Seems TW's reaction is a carbon copy to mine! He remains as a buy but fails this time to mention it reiterate any price target.
not too sure why TW has got his knickers in a twist tbh, he's rarely happy anyway!
surely, anyone who has invested in this or any other AR company did their DD and knew what he is about?
Pizzaman (TW) aint happy with the latest rns update ... unsurprising given it.s timing and revenue pattern comments so esrly sfter last update. Just sharing. Divn shoot the posty.
Reynolds ... yes . . should be remembered.
It was 30p once! Anyway, now Illumina are sorted he has the chance to prove it!
I remember when Reynolds said sp would be 30p if its wasn't for Illumina lol
post from someone on twitter
Based on previous experience, IMHO anything associated to Adam Reynolds needs a wide birth. Held over 40 directorships, 8 active.
#New #Cpt #Bst #Nipt Common theme = shareholder dilution or virtual wipeout. AR's remuneration extremely excessive too! #LifeStyle director.
Dibs ...I have to agree. The fact the bod stumped the 2nd tranche of cash up via subscription at the last minute shows that ii s werent willing to stump up the extra cash - certainly not at 10p anyway. We.ve bn told they.ll be another placing ...at least they.ll be time for the ii.s to privately peruse internal figs before parting with cash. I still see the future as positive. Ps when will the nomad be replaced?Got to happen surely ? Sorry if they.ve bn removed already. Mind, if not, why not? That.s a big question for me.
Could make a big difference; 'ramp up to very significant levels' lab should be up and running right now,.bring it on!!
The NIPT solution has been developed to enable lower cost NIPT testing to be applied on a broader population than has been possible to date. The Partner's NIPT service is expected to be fully operational by Q4 2018 and is anticipated to draw significant sample volumes from all over India.
NIPT is relatively new in the Indian market but, with over 26 million births per annum, and increasing awareness of the benefits of NIPT, Premaitha expects that India will be a key growth market for the Company and that this partnership will be a catalyst for the market.
Dr Stephen Little, CEO of Premaitha Health, commented: "Premaitha's NIPT system for this Partner brings together our world class assay and bioinformatics capabilities in the UK and Taiwan, applies higher sample throughput technology, and delivers a bespoke solution that puts NIPT in reach of large populations requiring cost effective screening. We believe the combination of our Partner's established position in India and Premaitha's NIPT technology, presents an opportunity for material revenue growth for the Company over the contract life and beyond as test volumes ramp up to very significant levels."
Main point for me is there enough funding to see this through to profit, and I believe there is.Apparently there are more well heeled and other investors that want to get onboard now that Illumina has been sorted, so funds should not be a problem, just at what cost??
Yes, they will need to step up on the sales, just hope there are plenty of irons in the fire, which I believe there are and India should start ramping up and showing some 'material' sales going forward.
It will be interesting to see how Lyn Rees will cut costs as for starters a few could be culled at the top end for me.
So, since we're now all agreed that more funding will be required despite Floridas incorrect reading of the RNS, How much do we think the company will require and how soon to the next placing? I'm going for another £2.5m within six months @ 7p. Not looking ahead further than that until we can see if growth at the previous rate resumes from the slowdown seen in the recent update.
Quite plain to see, Premaitha will need more funding,..not a problem,...thread closed!!
Sorry, your already in the deepest hole. If I bury you any deeper they will never find you.
Florida - I must admit that did bring a smile, no a laugh, as I clearly directed my ire at the wrong individual! :)
Apologies to Sorcerer. So come on then Florida over to you.....
Go on Sorcerer answer the questions.
For a person who claims to have magic powers (ie.Sorcerer) it seems to me that they may be necessary in order to produce your "Future Gold" prediction lol Perhaps you should get in touch with Lyn and puff away that £12m debt that has built up and no one wants to mention.
I'd be interested to know why you think all my comments lack any credibility when all I have done is extracted the FACTS from the companys results. I challenge you here to tell me what I have said that is untrue.
As for your dismissal of my suggestion of future fundraisings you clearly did not read the RNS properly. I will quote it here for you to remove any doubt:
"The new CEO is currently leading a strategic planning process which is due to deliver a revised business plan in the coming months, when the directors anticipate that further fundraising will be required to support the execution of that growth strategy and also ensure sufficient liquidity for the business. The Directors are confident that this can be achieved due to their strong track record of successful fundraising and their understanding of current levels of investor interest, along with the new management team and the ongoing support of investors now that the litigation risks have been resolved."
That is not a 'maybe' Sorcerer, a company cannot get any clearer than that. THEIR words not mine.
So, firstly, stop misleading people and secondly tell me what I have said that is incorrect.
I liked the update. There was at least more communication. Trade was better than we thought in H1. We know when we are getting the interims. All payments and actions have been completed in relation to the litigation. We know there will be an update on the strategic review by the AGM. A small step but positive.
http://www.premaitha.com/images/PDFs/Annual_Report_-_March_2018.pdf
Lyn is definitely on an IR offensive, which bodes well. One would expect the level of transparency around future forecasts and KPI’s to be evident at the AGM.